CLINICAL TRIALS PROFILE FOR OMNIPRED

All Clinical Trials for OMNIPRED

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00782717 ↗	A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients	Completed	Alcon Research	Phase 2	2008-11-01	The purpose of this study is to determine whether nepafenac is safe and effective for reducing the incidence of macular edema following cataract surgery in diabetic retinopathy patients.
NCT02229136 ↗	Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus	Active, not recruiting	Novartis Pharmaceuticals	Phase 2	2014-09-04	This is a randomized Phase 2 study to evaluate two different steroid-based mouth rinses (Miracle Mouth Wash plus hydrocortisone versus prednisolone oral rinse) for the prevention or treatment of everolimus-associated stomatitis (mouth sores) in postmenopausal patients undergoing treatment with an aromatase inhibitor plus everolimus. An exploratory analysis will also evaluate patient response to next anti-cancer therapy of physician's choice following discontinuation of therapy with an aromatase inhibitor plus everolimus.
NCT02229136 ↗	Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus	Active, not recruiting	US Oncology Research	Phase 2	2014-09-04	This is a randomized Phase 2 study to evaluate two different steroid-based mouth rinses (Miracle Mouth Wash plus hydrocortisone versus prednisolone oral rinse) for the prevention or treatment of everolimus-associated stomatitis (mouth sores) in postmenopausal patients undergoing treatment with an aromatase inhibitor plus everolimus. An exploratory analysis will also evaluate patient response to next anti-cancer therapy of physician's choice following discontinuation of therapy with an aromatase inhibitor plus everolimus.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Stanford University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	University of California, San Francisco	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Oregon Health and Science University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.

Clinical Trial Conditions for OMNIPRED

Condition Name

Condition Name for OMNIPRED
Intervention	Trials
Grafting, Corneal	1
Keratoplasty	1
Keratoplasty, Lamellar	1
Macular Edema	1

Condition MeSH

Condition MeSH for OMNIPRED
Intervention	Trials
Mucositis	1
Breast Neoplasms	1
Retinal Diseases	1
Macular Edema	1

Clinical Trial Locations for OMNIPRED

Trials by Country

Trials by Country for OMNIPRED
Location	Trials
United States	3

Trials by US State

Trials by US State for OMNIPRED
Location	Trials
Oregon	1
California	1
Texas	1

Clinical Trial Progress for OMNIPRED

Clinical Trial Phase

Clinical Trial Phase for OMNIPRED
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2

Clinical Trial Status

Clinical Trial Status for OMNIPRED
Clinical Trial Phase	Trials
Active, not recruiting	2
Completed	1

Clinical Trial Sponsors for OMNIPRED

Sponsor Name

Sponsor Name for OMNIPRED
Sponsor	Trials
Stanford University	1
University of California, San Francisco	1
Oregon Health and Science University	1

Sponsor Type

Sponsor Type for OMNIPRED
Sponsor	Trials
Other	4
Industry	3